Back to clinical trials listSarcomas

BFR ESS 01

Randomized Comparative Prospective Multicentre Phase II Trial Evaluating Clinical Impact of Interruption VS Maintenance of AI in Patients With Locally Advanced/ Metastatic LGESS

Open at Paris since : 11/07/2019
Target : Adult
Phase : Phase II

Trial description

The primary objective is to compare the progression-free survival (PFS) between aromatase inhibitors interruption and aromatase inhibitors maintenance strategies in patients with a locally advanced or metastatic Low Grade Endometrial Stromal Sarcoma (LGESS).

Url of the trial

Main investigator

SOPHIE PIPERNO-NEUMANN

Médecin

Contact